Table 3 Clinical Effectiveness

 Median Hours Used per Night (hours): Mean ± standard deviation

(range)

4.6 ± 2.5

(0.02–8.8)

4.2 ± 2.8

(0.0–9.4)

0.486

 Residual AHI (events/h):^a Mean ± standard deviation

(range)

3.2 ± 3.8

(0.0–18.1)

4.4 ± 7.1

(0.0–35.2)

0.347

 Residual AHI < 5 events/h: % (n)

81.6% (31)

82.7% (43)

1.000

 Median Hours Used per Night (hours): Mean ± standard deviation

(range)

4.6 ± 2.4

(0.02–8.9)

4.1 ± 2.6

(0.0–8.6)

0.355

 Residual AHI (events/h): Mean (range)

2.8 ± 2.6

(0.0–10.3)

3.6 ± 4.9

(0.0–30.3)

0.362

 Residual AHI < 5 events/h: % (n)

81.6% (31)

84.6% (44)

0.778

 Median Hours Used per Night (hours): Mean ± standard deviation

(range)

4.6 ± 2.5

(0.06–9.07)

4.0 ± 2.7

(0.0–9.13)

0.286

 Residual AHI (events/h): Mean ± standard deviation

(range)

2.6 ± 2.5

(0.0–10.1)

3.6 ± 5.4

(0.0–34.3)

0.292

 Residual AHI < 5 events/h: % (n)

86.8% (33)

82.7% (43)

0.770

 Adherent (≥4 h/night for > 70% of nights)

32% (12)

23% (12)

0.470

 Non-Adherent (< 4 h/night for < 70% of nights)

68% (26)

77% (40)

 Adherent and disease control (Residual AHI < 5 events/h)

32% (12)

21% (11)

0.330